Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine
NCT00521586
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1116
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
13 valent pneumococcal conjugate vaccine
BIOLOGICAL:
13 valent pneumococcal conjugate vaccine
Sponsor
Pfizer